Is PD-L1 a consistent biomarker for anti-PD-1 therapy? The model of balstilimab in a virally-driven tumor. Editorial Article uri icon

Overview

publication date

  • January 26, 2021

Research

keywords

  • B7-H1 Antigen
  • Biomarkers, Tumor
  • Immune Checkpoint Inhibitors
  • Neoplasms

Identity

PubMed Central ID

  • PMC7906900

Scopus Document Identifier

  • 85099773690

Digital Object Identifier (DOI)

  • 10.18632/oncotarget.19913

PubMed ID

  • 33500548

Additional Document Info

volume

  • 40

issue

  • 8